• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白阴性肝细胞癌诊断列线图模型的建立与验证

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma.

作者信息

Liu Long, Wang Qi, Zhao Xiaohong, Huang Yuxi, Feng Yuyi, Zhang Yu, Fang Zheping, Li Shaowei

机构信息

Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Zhejiang University, Linhai, Zhejiang, China.

Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

出版信息

Front Oncol. 2023 Feb 20;13:1131892. doi: 10.3389/fonc.2023.1131892. eCollection 2023.

DOI:10.3389/fonc.2023.1131892
PMID:36890811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986420/
Abstract

INTRODUCTION

As one of the most common malignant tumors in clinical practice, hepatocellular carcinoma (HCC) is a major threat to human health, where alpha-fetoprotein (AFP) is widely used for early screening and diagnoses. However, the level of AFP would not elevate in about 30-40% of HCC patients, which is clinically referred to as AFP-negative HCC, with small tumors at an early stage and atypical imaging features, making it difficult to distinguish benign from malignant by imaging alone.

METHODS

A total of 798 patients, with the majority being HBV-positive, were enrolled in the study and were randomized 2:1 to the training and validation groups. Univariate and multivariate binary logistic regression analyses were used to determine the ability of each parameter to predict HCC. A nomogram model was constructed based on the independent predictors.

RESULTS

A unordered multicategorical logistic regression analyses showed that the age, TBIL, ALT, ALB, PT, GGT and GPR help identify non-hepatic disease, hepatitis, cirrhosis, and hepatocellular carcinoma. A multivariate logistic regression analyses showed that the gender, age, TBIL, GAR, and GPR were independent predictors for the diagnosis of AFP-negative HCC. And an efficient and reliable nomogram model (AUC=0.837) was constructed based on independent predictors.

DISCUSSION

Serum parameters help reveal intrinsic differences between non-hepatic disease, hepatitis, cirrhosis, and HCC. The nomogram based on clinical and serum parameters could be used as a marker for the diagnosis of AFP-negative HCC, providing an objective basis for the early diagnosis and individualized treatment of hepatocellular carcinoma patients.

摘要

引言

作为临床实践中最常见的恶性肿瘤之一,肝细胞癌(HCC)对人类健康构成重大威胁,甲胎蛋白(AFP)被广泛用于早期筛查和诊断。然而,约30%-40%的HCC患者AFP水平不会升高,临床上称为AFP阴性HCC,其肿瘤早期较小且具有非典型影像学特征,仅靠影像学难以区分良恶性。

方法

本研究共纳入798例患者,多数为乙肝病毒阳性,按2:1随机分为训练组和验证组。采用单因素和多因素二元逻辑回归分析确定各参数预测HCC的能力。基于独立预测因子构建列线图模型。

结果

无序多分类逻辑回归分析显示,年龄、总胆红素(TBIL)、谷丙转氨酶(ALT)、白蛋白(ALB)、凝血酶原时间(PT)、γ-谷氨酰转肽酶(GGT)和甘氨酰脯氨酸二肽氨基肽酶(GPR)有助于识别非肝脏疾病、肝炎、肝硬化和肝细胞癌。多因素逻辑回归分析显示,性别、年龄、TBIL、GAR和GPR是诊断AFP阴性HCC的独立预测因子。并基于独立预测因子构建了一个高效可靠的列线图模型(曲线下面积[AUC]=0.837)。

讨论

血清参数有助于揭示非肝脏疾病、肝炎、肝硬化和HCC之间的内在差异。基于临床和血清参数的列线图可作为AFP阴性HCC诊断的标志物,为肝细胞癌患者的早期诊断和个体化治疗提供客观依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/9986420/e83f8a984c5b/fonc-13-1131892-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/9986420/e83f8a984c5b/fonc-13-1131892-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500e/9986420/e83f8a984c5b/fonc-13-1131892-g001.jpg

相似文献

1
Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma.甲胎蛋白阴性肝细胞癌诊断列线图模型的建立与验证
Front Oncol. 2023 Feb 20;13:1131892. doi: 10.3389/fonc.2023.1131892. eCollection 2023.
2
A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.接受根治性切除的甲胎蛋白阴性肝细胞癌患者早期复发的预测列线图。
Diagnostics (Basel). 2022 Apr 25;12(5):1073. doi: 10.3390/diagnostics12051073.
3
[Analysis of the diagnostic efficiency of combining multiple laboratory hematological indicators in alpha-fetoprotein-negative hepatocellular carcinoma].[多种实验室血液学指标联合诊断甲胎蛋白阴性肝细胞癌的效能分析]
Zhonghua Yi Xue Za Zhi. 2022 May 10;102(17):1303-1310. doi: 10.3760/cma.j.cn112137-20220115-00103.
4
Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma.纤维蛋白原与前白蛋白比值及γ-谷氨酰转肽酶与血小板比值在甲胎蛋白阴性肝细胞癌进展中的诊断价值
Cancer Cell Int. 2020 Mar 12;20:77. doi: 10.1186/s12935-020-1161-y. eCollection 2020.
5
Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.高敏C反应蛋白检测对乙型肝炎相关性肝硬化患者肝细胞癌诊断的评估
Oncol Lett. 2017 May;13(5):3457-3464. doi: 10.3892/ol.2017.5890. Epub 2017 Mar 22.
6
A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.一种基于血清生物标志物的新型在线计算器,用于检测乙型肝炎患者的肝细胞癌。
Clin Chem. 2019 Dec;65(12):1543-1553. doi: 10.1373/clinchem.2019.308965. Epub 2019 Oct 31.
7
Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.用于预测接受局部区域治疗且甲胎蛋白动态变化的肝细胞癌患者复发的列线图的开发与验证。
Front Oncol. 2023 Aug 28;13:1206345. doi: 10.3389/fonc.2023.1206345. eCollection 2023.
8
Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.用于甲胎蛋白阴性肝细胞癌诊断及移植后预后的代谢组学生物标志物
Front Oncol. 2023 Feb 9;13:1072775. doi: 10.3389/fonc.2023.1072775. eCollection 2023.
9
Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers.基于血清生物标志物的甲胎蛋白阴性肝细胞癌诊断列线图的开发
World J Gastrointest Oncol. 2024 Jun 15;16(6):2463-2475. doi: 10.4251/wjgo.v16.i6.2463.
10
The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.血清甲胎蛋白检测早期肝细胞癌的性能受抗病毒治疗和血清天门冬氨酸氨基转移酶的影响:一项在乙型肝炎病毒感染患者大队列中的研究。
Viruses. 2022 Jul 29;14(8):1669. doi: 10.3390/v14081669.

引用本文的文献

1
Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study.甲胎蛋白阴性的晚期肝癌患者的临床结局:一项回顾性队列研究的倾向匹配分析
J Hepatocell Carcinoma. 2025 Jun 27;12:1241-1252. doi: 10.2147/JHC.S527332. eCollection 2025.
2
A cost-effective predictive tool for AFP-negative focal hepatic lesions of retrospective study: enhancing clinical triage and decision-making.一项用于AFP阴性局灶性肝病变回顾性研究的经济高效预测工具:加强临床分诊与决策制定。
PeerJ. 2025 Mar 26;13:e19150. doi: 10.7717/peerj.19150. eCollection 2025.
3
Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.γ-谷氨酰转肽酶/血小板比值预测合并慢性乙型肝炎和非酒精性脂肪性肝病患者的肝纤维化。
J Clin Lab Anal. 2022 Aug;36(8):e24596. doi: 10.1002/jcla.24596. Epub 2022 Jul 9.
3
The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma.鲽鱼钙蛋白2在肝细胞癌中的致癌及诊断潜力
用于预测慢性乙型肝炎患者肝细胞癌风险的可解释机器学习模型的开发与验证:一项病例对照研究
BMC Gastroenterol. 2025 Mar 11;25(1):157. doi: 10.1186/s12876-025-03697-2.
4
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer.甲胎蛋白(AFP)、甲胎蛋白异质体-L3(AFP-L3)、异常凝血酶原(DCP)、糖类抗原199(CA199)及其联合检测对原发性肝癌的诊断效能
J Hepatocell Carcinoma. 2025 Mar 6;12:513-526. doi: 10.2147/JHC.S499966. eCollection 2025.
5
Serum miRNA-101 expression signature as non-invasive diagnostic biomarker for Hepatitis C virus-associated hepatocellular carcinoma in Egyptian patients.血清miRNA-101表达特征作为埃及患者丙型肝炎病毒相关肝细胞癌的非侵入性诊断生物标志物。
Sci Rep. 2025 Jan 3;15(1):645. doi: 10.1038/s41598-024-81207-2.
6
Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers.基于血清生物标志物的甲胎蛋白阴性肝细胞癌诊断列线图的开发
World J Gastrointest Oncol. 2024 Jun 15;16(6):2463-2475. doi: 10.4251/wjgo.v16.i6.2463.
7
Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.β2微球蛋白作为肝细胞癌预后的预测生物标志物及新型列线图的构建
J Hepatocell Carcinoma. 2023 Oct 11;10:1813-1825. doi: 10.2147/JHC.S425344. eCollection 2023.
8
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.除了肝癌,甲胎蛋白在临床实践中还有更多的应用场景。
Front Oncol. 2023 Sep 15;13:1231420. doi: 10.3389/fonc.2023.1231420. eCollection 2023.
J Hepatocell Carcinoma. 2022 Mar 8;9:141-155. doi: 10.2147/JHC.S351882. eCollection 2022.
4
LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.LDH 和 GGT/ALT 比值可作为肝癌肝移植术后患者的新型预后生物标志物。
Comput Math Methods Med. 2021 Nov 20;2021:9809990. doi: 10.1155/2021/9809990. eCollection 2021.
5
Dual Tumor Microenvironment Remodeling by Glucose-Contained Radical Copolymer for MRI-Guided Photoimmunotherapy.基于含葡萄糖的自由基共聚物的双重肿瘤微环境重塑用于 MRI 引导的光免疫治疗。
Adv Mater. 2022 Jun;34(25):e2107674. doi: 10.1002/adma.202107674. Epub 2021 Nov 17.
6
Engineering nanotheranostic strategies for liver cancer.用于肝癌的工程化纳米诊疗策略。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1213-1228. doi: 10.4251/wjgo.v13.i10.1213.
7
Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy.外泌体衍生 miRNA 在癌症进展和治疗中的表达、调控及功能。
FASEB J. 2021 Oct;35(10):e21916. doi: 10.1096/fj.202100294RR.
8
Concordance between hepatic biopsy and the APRI index (Ast to Platelet Ratio Index) for the diagnosis of cirrhosis in patients with autoimmune liver disease.肝活检与 APRI 指数(天冬氨酸转氨酶与血小板比值指数)在自身免疫性肝病患者肝硬化诊断中的一致性。
Gastroenterol Hepatol. 2021 Aug-Sep;44(7):465-471. doi: 10.1016/j.gastrohep.2020.07.005. Epub 2021 Feb 16.
9
Serum AFU, GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value.原发性肝癌患者血清 AFU、GGT 和 TK1 水平及其与临床病理的相关性和诊断价值。
Cell Mol Biol (Noisy-le-grand). 2020 Jul 31;66(5):111-116.
10
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.《2019年中国肝细胞癌管理临床指南:更新与见解》
Hepatobiliary Surg Nutr. 2020 Aug;9(4):452-463. doi: 10.21037/hbsn-20-480.